https://doi.org/10.4081/monaldi.2006.564

Primary alveolar hypoventilation and XXXXY chromosopathy

Vol. 65 No. 3 (2006): Pulmonary series
Submitted: February 11, 2016
Accepted: February 11, 2016
Published: February 11, 2016
Primary alveolar hypoventilation, chromosome diseases, noninvasive ventilation
Abstract Views: 575
PDF: 406
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

D. Samolski
dsamolski@hsp.santpau.es
Pneumology Dept. Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
A. Antón
Pneumology Dept. Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
M. Mayos
Pneumology Dept. Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
M. Subirana
Cardiology Dept. Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
R. Güell
Pneumology Dept. Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
The association of primary alveolar hypoventilation (PAH) and chromosomic diseases has not been described previously. A 19 year-old man with Fraccaro’s syndrome (XXXXY karyotype) was admitted to evaluate chronic hypercapnic respiratory failure, pulmonary arterial hypertension and cor pulmonale. PAH was diagnosed. As effective treatment, such as non-invasive positive pressure ventilation (NIPPV), is available for this disorder we should intensify the search for PAH in patients with chromosome disease.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

How to Cite

Samolski, D., A. Antón, M. Mayos, M. Subirana, and R. Güell. 2016. “Primary Alveolar Hypoventilation and XXXXY Chromosopathy”. Monaldi Archives for Chest Disease 65 (3). https://doi.org/10.4081/monaldi.2006.564.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.